Duality Biotherapeutics, Inc. 09606.HK Price Prediction & Forecast

Q: How do technical analysis indicators apply to 09606.HK?

According to technical analysis, Duality Biotherapeutics, Inc. has an aggregate signal of Buy. Duality Biotherapeutics, Inc. has 3 Buy signals, 2 Neutral Signals and 2 sell signals.

Q: What are the Fibonacci retracement levels for 09606.HK?

The Fibonacci retracement level for Duality Biotherapeutics, Inc. is between 38.2% and 50%

Q: What is the RSI for Duality Biotherapeutics, Inc.?

The RSI for Duality Biotherapeutics, Inc. is currently 57.62, indicating a neutral condition

Q: What is Duality Biotherapeutics, Inc. price for the next 12 months?

Duality Biotherapeutics, Inc. 09606.HK price for the next 12 months is estimated at $0.

Q: How high is Duality Biotherapeutics, Inc. expected to go?

According to wall street analysts, Duality Biotherapeutics, Inc. is expected to reach a high forecast of $0.

Home

Stock

09606.HK

Forecast

DUALITYBIO-B (09606.HK)

Duality Biotherapeutics, Inc.

HK$343

0.7%

$2.39

CLOSED_MARKET: Feb 16, 12:00:00 HKT

Key Stats

Prev.Close

$336

Open

$340.6

Day's Range

$332.2 - $343

52 week range

$165.5 - $563.5

Volume

37.9K

Avg.Volume

773.0K

EPS (TTM)

-36.20

Dividend yield

Market Cap

$30.1B

What is DUALITYBIO-B?

Duality Biotherapeutics, Inc. operates as a clinical stage company. The company is headquartered in Shanghai, Shanghai and currently employs 191 full-time employees. The company went IPO on 2025-04-15. The firm is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The firm's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The firm's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The firm principally conducts its businesses in domestic and overseas markets.



Features

AI Copilot for Stock & Crypto

Resources

Market

09606.HK Stock Price Prediction Summary

09606.HK stock price ended at $338.6 on Monday, after rising 0.77%

On the latest trading day Feb 16, 2026, the stock price of 09606.HK rose by 0.77%, climbing from $340.60 to $338.60. Throughout the session, the stock experienced a volatility of 1.67%, with prices fluctuating between a daily low of $335.00 and a high of $340.60. Alongside this price increase, trading volume also rose by 397.6K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 4.5K shares were traded, amounting to a market value of approximately $29.8B.

09606.HK Technical Signals

Technical Signals Summary

Buy Signals 3

Neutral Signals 2

Sell Signals 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

09606.HK currently exhibits 3 buy signals and 2 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of 3.55% during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.

Bullish/Bearish Signals for 09606.HK

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for 09606.HK. These insights help you make informed investment decisions.

Follow-Up Questions

How do technical analysis indicators apply to 09606.HK?



What are the Fibonacci retracement levels for 09606.HK?



What is the RSI for Duality Biotherapeutics, Inc.?



What is Duality Biotherapeutics, Inc. price for the next 12 months?



How high is Duality Biotherapeutics, Inc. expected to go?



Duality Biotherapeutics, Inc. (09606.HK) Price

09606.HK Stock Price Chart